Renalytix (LON:RENX) Stock Breaks Above Fifty Day Moving Average – Here’s What Happened

Renalytix Plc (LON:RENX)’s stock price passed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of GBX 5.47 and traded as high as GBX 5.48. Renalytix shares last traded at GBX 5.48, with a volume of 318,458 shares changing hands.

Renalytix Price Performance

The company has a current ratio of 1.57, a quick ratio of 2.42 and a debt-to-equity ratio of -483.33. The company has a market cap of £36.29 million, a PE ratio of -1.35 and a beta of 1.71. The stock has a fifty day simple moving average of GBX 5.47 and a two-hundred day simple moving average of GBX 3.59.

Insider Buying and Selling

In other Renalytix news, insider Christopher H. B. Mills sold 1,166,667 shares of the stock in a transaction dated Tuesday, September 29th. The shares were sold at an average price of GBX 6, for a total value of £70,000.02. Corporate insiders own 5.99% of the company’s stock.

About Renalytix

Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S. Food and Drug Administration and which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com).